BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1732 related articles for article (PubMed ID: 28669641)

  • 21. Tumor necrosis adds prognostically significant information to grade in clear cell renal cell carcinoma: A study of 842 consecutive cases from a single institution. Khor LY, Dhakal HP, Jia X, Reynolds JP, McKenney JK, Rini BI, Magi-Galluzzi C, Przybycin CG.Am J Surg Pathol. September 2016;40(9):1224-1231.
    Kryvenko ON
    Urol Oncol; 2017 Jun; 35(6):454-455. PubMed ID: 28416108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors.
    Moch H; Gasser T; Amin MB; Torhorst J; Sauter G; Mihatsch MJ
    Cancer; 2000 Aug; 89(3):604-14. PubMed ID: 10931460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome.
    Cornejo KM; Dong F; Zhou AG; Wu CL; Young RH; Braaten K; Sadow PM; Nielsen GP; Oliva E
    Hum Pathol; 2015 Oct; 46(10):1411-7. PubMed ID: 26297250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tubulocystic renal cell carcinoma with poorly differentiated foci is indicative of aggressive behavior: clinicopathologic study of two cases and review of the literature.
    Zhao M; Teng X; Ru G; Zhao Z; Hu Q; Han L; He X
    Int J Clin Exp Pathol; 2015; 8(9):11124-31. PubMed ID: 26617832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma.
    Lee SE; Byun SS; Oh JK; Lee SC; Chang IH; Choe G; Hong SK
    J Urol; 2006 Oct; 176(4 Pt 1):1332-7; discussion 1337-8. PubMed ID: 16952624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of Clear Cell Papillary Renal Cell Carcinoma in Low-Grade Renal Cell Carcinoma Cases: A 12-Year Retrospective Clinicopathologic Study From a Single Cancer Center.
    Gill S; Kauffman EC; Kandel S; George S; Schwaab T; Xu B
    Int J Surg Pathol; 2016 May; 24(3):207-12. PubMed ID: 26510859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired Cystic Disease-associated Renal Cell Carcinoma (ACD-RCC): A Multiinstitutional Study of 40 Cases With Clinical Follow-up.
    Przybycin CG; Harper HL; Reynolds JP; Magi-Galluzzi C; Nguyen JK; Wu A; Sangoi AR; Liu PS; Umar S; Mehra R; Zhang X; Cox RM; McKenney JK
    Am J Surg Pathol; 2018 Sep; 42(9):1156-1165. PubMed ID: 29851703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness.
    Sengupta S; Lohse CM; Leibovich BC; Frank I; Thompson RH; Webster WS; Zincke H; Blute ML; Cheville JC; Kwon ED
    Cancer; 2005 Aug; 104(3):511-20. PubMed ID: 15973740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?
    Brookman-May SD; May M; Wolff I; Zigeuner R; Hutterer GC; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Feciche B; Figenshau RS; Madison K; Sánchez-Chapado M; Santiago Martin Mdel C; Salzano L; Lotrecchiano G; Zastrow S; Wirth M; Sountoulides P; Shariat S; Waidelich R; Stief C; Gunia S; ;
    Eur Urol; 2015 May; 67(5):943-51. PubMed ID: 25684695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Langerhans Cell Histiocytosis Associated With Renal Cell Carcinoma Is a Neoplastic Process: Clinicopathologic and Molecular Study of 7 Cases.
    Agaimy A; Bonert M; Naqvi A; Wang C; Trpkov K; Dettmar P; Wintzer HO; Stoehr R; Hes O; Williamson SR; Gibson IW; Hartmann A
    Am J Surg Pathol; 2020 Dec; 44(12):1658-1665. PubMed ID: 32910018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal cell carcinoma in kidney allografts: histologic types, including biphasic papillary carcinoma.
    Troxell ML; Higgins JP
    Hum Pathol; 2016 Nov; 57():28-36. PubMed ID: 27396934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathologic and clinical characteristics of early onset renal cell carcinoma.
    Clemmensen T; Matoso A; Graham T; Lai WS; Rais-Bahrami S; Gordetsky J
    Hum Pathol; 2018 Apr; 74():25-31. PubMed ID: 29133143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clear cell papillary renal cell carcinoma: a clinicopathologic analysis of 6 cases.
    Yan WX; Cao WR; Zhao J; Zhang W; Wang XL; Yuan Q; Dang SQ
    Int J Clin Exp Pathol; 2015; 8(5):4595-9. PubMed ID: 26191150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma].
    Zhang W; Chu J; Zou YW; Jiang YX; Wei ZM; Zhong DC; Liu Y; Li YJ; Yu WJ
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):120-126. PubMed ID: 30695864
    [No Abstract]   [Full Text] [Related]  

  • 35. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
    Amin MB; Paner GP; Alvarado-Cabrero I; Young AN; Stricker HJ; Lyles RH; Moch H
    Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma.
    Kara O; Maurice MJ; Zargar H; Malkoc E; Akca O; Andrade HS; Ramirez D; Caputo PA; Nelson RJ; Rini B; Kaouk JH
    Int Urol Nephrol; 2016 Aug; 48(8):1253-1260. PubMed ID: 27215555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unclassified renal cell carcinoma: a report of 56 cases.
    Lopez-Beltran A; Kirkali Z; Montironi R; Blanca A; Algaba F; Scarpelli M; Yorukoglu K; Hartmann A; Cheng L
    BJU Int; 2012 Sep; 110(6):786-93. PubMed ID: 22404824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up.
    Minardi D; Lucarini G; Filosa A; Milanese G; Zizzi A; Di Primio R; Montironi R; Muzzonigro G
    Int J Immunopathol Pharmacol; 2008; 21(2):447-55. PubMed ID: 18547492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The WHO/ISUP grading system for renal carcinoma].
    Moch H
    Pathologe; 2016 Jul; 37(4):355-60. PubMed ID: 27271258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 87.